Anti-3-[(18)F]FACBC positron emission tomography-computerized tomography and (111)In-capromab pendetide single photon emission computerized tomography-computerized tomography for recurrent prostate carcinoma: results of a prospective clinical trial.

Schuster, David M

Anti-3-[(18)F]FACBC positron emission tomography-computerized tomography and (111)In-capromab pendetide single photon emission computerized tomography-computerized tomography for recurrent prostate carcinoma: results of a prospective clinical trial. [electronic resource] - The Journal of urology May 2014 - 1446-53 p. digital

Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1527-3792

10.1016/j.juro.2013.10.065 doi


Aged
Aged, 80 and over
Antibodies, Monoclonal
Carboxylic Acids
Carcinoma--diagnosis
Cyclobutanes
Humans
Indium Radioisotopes
Male
Middle Aged
Multimodal Imaging
Neoplasm Recurrence, Local--diagnosis
Positron-Emission Tomography
Prospective Studies
Prostatic Neoplasms--diagnosis
Tomography, Emission-Computed, Single-Photon
Tomography, X-Ray Computed